Incyte Corp.
(NASDAQ : INCY)

( )
INCY After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.01%72.511.0%$1888.07m
AMGNAmgen, Inc. -2.43%197.811.3%$881.42m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$848.08m
BIIBBiogen, Inc. -7.31%293.271.5%$703.75m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$557.47m
MRNAModerna, Inc. -0.94%29.670.0%$530.64m
ILMNIllumina, Inc. -6.10%256.463.5%$443.43m
ALXNAlexion Pharmaceuticals, Inc. 0.16%89.932.0%$286.49m
AAgilent Technologies, Inc. -3.67%68.991.6%$220.20m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$187.28m
INCYIncyte Corp. 1.30%74.182.5%$178.88m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$164.58m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$163.42m
NVAXNovavax, Inc. 3.31%14.03114.7%$128.96m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$98.37m

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.